Cortical superficial siderosis: Detection and clinical significance in cerebral amyloid angiopathy and related conditions

Brain

Volumn 138, Issue 8, 2015, Pages 2126-2139

  Charidimou, Andreas ^a,b   Linn, Jennifer ^c   Vernooij, Meike W ^d   Opherk, Christian ^c,e   Akoudad, Saloua ^d   Baron, Jean Claude ^f   Greenberg, Steven M ^b   Jäger, Hans Rolf ^a   Werring, David J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e SLK Kliniken Heilbronn   (Germany)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

cerebral amyloid angiopathy; cortical superficial siderosis; intracerebral haemorrhage; magnetic resonance imaging; small vessel disease

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; APIXABAN; DABIGATRAN; EDOXABAN; HEMOSIDERIN; IMMUNOLOGIC AGENT; RIVAROXABAN;

ALZHEIMER DISEASE; ARTERY CATHETERIZATION; BRAIN HEMORRHAGE; BRAIN STEM; CEREBELLUM; CLINICAL TRIAL (TOPIC); CORTICAL SUPERFICIAL SIDEROSIS; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DIGITAL SUBTRACTION ANGIOGRAPHY; HEMISPHERE; HIGH RISK PATIENT; HUMAN; IMMUNIZATION; MEDICAL DECISION MAKING; MEDICAL TERMINOLOGY; MEMORY DISORDER; MULTICENTER STUDY (TOPIC); NEUROIMAGING; NEUROLOGIC DISEASE; NEUROLOGIST; NUCLEAR MAGNETIC RESONANCE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME; REVIEW; RISK ASSESSMENT; SIDEROSIS; SUBARACHNOID HEMORRHAGE; SUBARACHNOID SPACE; SUSCEPTIBILITY WEIGHTED IMAGING; SYSTEMATIC REVIEW; VASCULAR AMYLOIDOSIS; ANIMAL; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL HEMORRHAGE; COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES;

ANIMALS; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL HEMORRHAGE; HUMANS; MAGNETIC RESONANCE IMAGING; PREVALENCE; SIDEROSIS;

EID: 84940055851     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv162     Document Type: Review

References (109)

1. Arima H, Tzourio C, Anderson C, Woodward M, Bousser MG, MacMahon S, et al. Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke 2010; 41: 394-6.
2. Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol 2011; 69: 320-7.
3. Atlas SW, Mark AS, Grossman RI, Gomori JM. Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications. Radiology 1988; 168: 803-7.
4. Baron JC, Farid K, Dolan E, Turc G, Marrapu ST, O'Brien E, et al. Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage. J Cereb Blood flow Metab 2014; 34: 753-8.
5. Baumann CR, Schuknecht B, Lo Russo G, Cossu M, Citterio A, Andermann F, et al. Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed. Epilepsia 2006; 47: 563-6.
6. Beitzke M, Gattringer T, Enzinger C, Wagner G, Niederkorn K, Fazekas F. Clinical presentation, etiology, and long-term prognosis in patients with nontraumatic convexal subarachnoid hemorrhage. Stroke 2011; 42: 3055-60.
7. Biffi A, Halpin A, Towfighi A, Gilson A, Busl K, Rost N, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology 2010; 75: 693-8.
8. Brunot S, Osseby GV, Rouaud O, Kazemi A, Ricolfi F, Couvreur G, et al. Transient ischaemic attack mimics revealing focal subarachnoid haemorrhage. Cerebrovasc Dis 2010; 30: 597-601.
9. Charidimou A, Baron JC, Werring DJ. Transient focal neurological episodes, cerebral amyloid angiopathy, and intracerebral hemorrhage risk: looking beyond TIAs. Int J Stroke 2013a; 8: 105-8.
10. Charidimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 2012a; 83: 124-37.
11. Charidimou A, Jager RH, Fox Z, Peeters A, Vandermeeren Y, Laloux P, et al. Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy. Neurology 2013b; 81: 626-32.
12. Charidimou A, Jaunmuktane Z, Baron JC, Burnell M, Varlet P, Peeters A, et al. White matter perivascular spaces: An MRI marker in pathology-proven cerebral amyloid angiopathy? Neurology 2014; 82: 57-62.
13. Charidimou A, Law R, Werring DJ. Amyloid "spells" trouble. Lancet 2012b; 380: 1620.
14. Charidimou A, Martinez-Ramirez S, Shoamanesh A, Oliveira-Filho J, Frosch M, Vashkevich A, et al. Cerebral amyloid angiopathy with and without hemorrhage: Evidence for different disease phenotypes. Neurology 2015; 84: 1206-12.
15. Charidimou A, Peeters A, Fox Z, Gregoire SM, Vandermeeren Y, Laloux P, et al. Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre magnetic resonance imaging cohort study and meta-analysis. Stroke 2012c; 43: 2324-30.
16. Charidimou A, Peeters AP, Jager R, Fox Z, Vandermeeren Y, Laloux P, et al. Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy. Neurology 2013c; 81: 1666-73.
17. Cheng AL, Batool S, McCreary CR, Lauzon ML, Frayne R, Goyal M, et al. Susceptibility-weighted imaging is more reliable than T2∗-weighted gradient-recalled echo MRI for detecting microbleeds. Stroke 2013; 44: 2782-6.
18. Cianchetti FA, Nishimura N, Schaffer CB. Cortical microhaemorrhages reduce stimulus-evoked calcium responses in nearby neurons. J Cereb Blood Flow Metabo 2009; 29: S217-S8.
19. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-51.
20. Cuvinciuc V, Viguier A, Calviere L, Raposo N, Larrue V, Cognard C, et al. Isolated acute nontraumatic cortical subarachnoid hemorrhage. Am J Neuroradiol 2010; 31: 1355-62.
21. De Reuck J, Deramecourt V, Cordonnier C, Auger F, Durieux N, Pasquier F, et al. Superficial siderosis of the central nervous system: a post-mortem 7.0-tesla magnetic resonance imaging study with neuropathological correlates. Cerebrovasc Dis 2013; 36: 412-7.
22. Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 2011; 17: 439-47.
23. Dreier JP, Ebert N, Priller J, Megow D, Lindauer U, Klee R, et al. Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg 2000; 93: 658-66.
24. Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012; 11: 906-17.
25. Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007; 130(Pt 12): 3091-101.
26. Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG. Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke 2010; 41: 2505-11.
27. Fearnley JM, Stevens JM, Rudge P. Superficial siderosis of the central nervous system. Brain 1995; 118 (Pt 4): 1051-66.
28. Feldman HH, Maia LF, Mackenzie IR, Forster BB, Martzke J, Woolfenden A. Superficial siderosis: a potential diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease. Stroke 2008; 39: 2894-7.
29. Field DK, Kleinig TJ. Aura attacks from acute convexity subarachnoid haemorrhage not due to cerebral amyloid angiopathy. Cephalalgia 2011; 31: 368-71.
30. Finelli PF. Cerebral amyloid angiopathy as cause of convexity SAH in elderly. Neurologist 2010; 16: 37-40.
31. Geraldes R, Sousa PR, Fonseca AC, Falcao F, Canhao P, Pinho e Melo T. Nontraumatic convexity subarachnoid hemorrhage: different etiologies and outcomes. J Stroke Cerebrovasc Dis 2014; 23: e23-30.
32. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013; 369: 2093-104.
33. Goos JD, van der Flier WM, Knol DL, Pouwels PJ, Scheltens P, Barkhof F, et al. Clinical relevance of improved microbleed detection by susceptibility-weighted magnetic resonance imaging. Stroke 2011; 42: 1894-900.
34. Goulenok T, Klein I, Mazighi M, Messika-Zeitoun D, Alexandra JF, Mourvillier B, et al. Infective endocarditis with symptomatic cerebral complications: contribution of cerebral magnetic resonance imaging. Cerebrovasc Dis 2013; 35: 327-36.
35. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. New Engl J Med 2011; 365: 981-92.
36. Greenberg SM. Small vessels, big problems. N Engl J Med 2006; 354: 1451-3.
37. Greenberg SM, Eng JA, Ning M, Smith EE, Rosand J. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 2004; 35: 1415-20.
38. Greenberg SM, Finklestein SP, Schaefer PW. Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI. Neurology 1996; 46: 1751-4.
39. Greenberg SM, Salman RA, Biessels GJ, van Buchem M, Cordonnier C, Lee JM, et al. Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol 2014; 13: 419-28.
40. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009; 8: 165-74.
41. Greenberg SM, Vonsattel JP, Stakes JW, Gruber M, Finklestein SP. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993; 43: 2073-9.
42. Gregoire SM, Charidimou A, Gadapa N, Dolan E, Antoun N, Peeters A, et al. Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study. Brain 2011; 134(Pt 8): 2376-86.
43. Gregoire SM, Werring DJ, Chaudhary UJ, Thornton JS, Brown MM, Yousry TA, et al. Choice of echo time on GRE T2∗-weighted MRI influences the classification of brain microbleeds. Clin Radiol 2010; 65: 391-4.
44. Gurol ME, Dierksen G, Betensky R, Gidicsin C, Halpin A, Becker A, et al. Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology 2012; 79: 320-6.
45. Gurol ME, Viswanathan A, Gidicsin C, Hedden T, Martinez-Ramirez S, Dumas A, et al. Cerebral amyloid angiopathy burden associated with leukoaraiosis: A positron emission tomography/magnetic resonance imaging study. Ann Neurol 2013; 73: 529-36.
46. Haacke EM, Boikov AS, Barnes E, Neelavalli J, Khan MA. Susceptibility-weighted imaging. In: Werring DJ, editor. Cerebral microbleeds: pathophysiology to clinical practice. Cambridge University Press; 2011. p. 22-33.
47. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. Am J Neuroradiol 2009; 30: 19-30.
48. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med 2004; 52: 612-8.
49. Hajj-Ali RA, Singhal AB, Benseler S, Molloy E, Calabrese LH. Primary angiitis of the CNS. Lancet Neurol 2011; 10: 561-72.
50. Hamill R Report of a case of melanosis of the brain, cord and meninges. J Nerv Ment Dis 1908:594.
51. Hammen T, Romstock J, Dorfler A, Kerling F, Buchfelder M, Stefan H. Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy. Seizure 2007; 16: 248-53.
52. Itoh Y, Yamada M. Cerebral amyloid angiopathy in the elderly: the clinicopathological features, pathogenesis, and risk factors. J Med Dental Sci 1997; 44: 11-9.
53. Itoh Y, Yamada M, Hayakawa M, Otomo E, Miyatake T. Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 1993; 116: 135-41.
54. Join-Lambert C, Hodel J, Tamazyan R, Gerber S, Bruander M, Zuber M. Are silent ischemic infarcts in cerebral amyloid angiopathy associated with subarachnoid hemorrhage? Cerebrovas Dis 2013; 35(Suppl. 3):409.
55. Katoh M, Yoshino M, Asaoka K, Aoki T, Imamura H, Kashiwazaki D, et al. A restricted subarachnoid hemorrhage in the cortical sulcus in cerebral amyloid angiopathy: could it be a warning sign? Surg Neurol 2007; 68: 457-60.
56. Kawahara I, Nakamoto M, Matsuo Y, Tokunaga Y. A case of cerebral amyloid angiopathy in which a restricted subarachnoid hemorrhage recurred in the cortical sulcus following a subcortical hemorrhage [in Japanese]. No Shinkei Geka 2010; 38: 551-5.
57. Keage HA, Carare RO, Friedland RP, Ince PG, Love S, Nicoll JA, et al. Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. BMC Neurol 2009; 9: 3.
58. Khurram A, Kleinig T, Leyden J. Clinical associations and causes of convexity subarachnoid hemorrhage. Stroke 2014; 45: 1151-3.
59. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001; 56: 537-9.
60. Koeppen AH, Barron KD. Superficial siderosis of the central nervous system. A histological, histochemical and chemical study. J Neuropathol Exp Neurol 1971; 30: 448-69.
61. Koeppen AH, Dickson AC, Chu RC, Thach RE. The pathogenesis of superficial siderosis of the central nervous system. Ann Neurol 1993; 34: 646-53.
62. Koeppen AH, Michael SC, Li D, Chen Z, Cusack MJ, Gibson WM, et al. The pathology of superficial siderosis of the central nervous system. Acta Neuropathol 2008; 116: 371-82.
63. Kumar N, Cohen-Gadol AA, Wright RA, Miller GM, Piepgras DG, Ahlskog JE. Superficial siderosis. Neurology 2006; 66: 1144-52.
64. Kumar S, Goddeau RP, Selim MH, Thomas A, Schlaug G, Alhazzani A, et al. Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology 2010; 74: 893-9.
65. Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 2010; 74: 1346-50.
66. Linn J, Herms J, Dichgans M, Bruckmann H, Fesl G, Freilinger T, et al. Subarachnoid hemosiderosis and superficial cortical hemosiderosis in cerebral amyloid angiopathy. Am J Neuroradiol 2008; 29: 184-6.
67. Linn J, Michl S, Katja B, Pfefferkorn T, Wiesmann M, Hartz S, et al. Cortical vein thrombosis: the diagnostic value of different imaging modalities. Neuroradiology 2010; 52: 899-911.
68. Linn J, Wollenweber FA, Lummel N, Bochmann K, Pfefferkorn T, Gschwendtner A, et al. Superficial siderosis is a warning sign for future intracranial hemorrhage. J Neurol 2013; 260: 176-81.
69. Maas MB, Nemeth AJ, Rosenberg NF, Kosteva AR, Guth JC, Liotta EM, et al. Subarachnoid extension of primary intracerebral hemorrhage is associated with poor outcomes. Stroke 2013; 44: 653-7.
70. Maia LF, Mackenzie IR, Feldman HH. Clinical phenotypes of cerebral amyloid angiopathy. J Neurol Sci 2007; 257: 23-30.
71. Martinez-Ramirez S, Pontes-Neto OM, Dumas AP, Auriel E, Halpin A, Quimby M, et al. Topography of dilated perivascular spaces in subjects from a memory clinic cohort. Neurology 2013; 80: 1551-6.
72. Mas J, Bouly S, Mourand I, Renard D, de Champfleur N, Labauge P. Focal convexal subarachnoid hemorrhage: clinical presentation, imaging patterns and etiologic findings in 23 patients [in French]. Rev Neurol (Paris) 2013; 169: 59-66.
73. Mehndiratta P, Mendel TA. Cortical superficial siderosis, APOE genotype, and hemorrhage risk in cerebral amyloid angiopathy. Neurology 2015; 84: 1190-1.
74. Mittal S, Wu Z, Neelavalli J, Haacke EM. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 2009; 30: 232-52.
75. Na HK, Park JH, Kim JH, Kim HJ, Kim ST, Werring DJ, et al. Cortical superficial siderosis: A marker of vascular amyloid in patients with cognitive impairment. Neurology 2015; 84: 849-55.
76. Nandigam RN, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J, et al. MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. Am J Neuroradiol 2009; 30: 338-43.
77. Oehmichen M, Raff G. Timing of cortical contusion. Correlation between histomorphologic alterations and post-traumatic interval. Zeitschrift fur Rechtsmedizin 1980; 84: 79-94.
78. Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, et al. Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch Neurol 2012; 69: 198-207.
79. Panda S, Prashantha DK, Shankar SR, Nagaraja D. Localized convexity subarachnoid haemorrhage-a sign of early cerebral venous sinus thrombosis. Eur J Neurol 2010; 17: 1249-58.
80. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9: 689-701.
81. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New Engl J Med 2011; 365: 883-91.
82. Paterson RW, Uchino K, Emsley HC, Pullicino P. Recurrent stereotyped episodes in cerebral amyloid angiopathy: response to migraine prophylaxis in two patients. Cerebrovasc Dis Extra 2013; 3: 81-4.
83. Peca S, McCreary CR, Donaldson E, Kumarpillai G, Shobha N, Sanchez K, et al. Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy. Neurology 2013; 81: 1659-65.
84. Profice P, Pilato F, Della GM, Colosimo C, Gaudino S, Arena V, et al. Recurrent subarachnoid bleeding and superficial siderosis in a patient with histopathologically proven cerebral amyloid angiopathy. Case Rep Neurol 2011; 3: 124-8.
85. Rannikmae K, Kalaria RN, Greenberg SM, Chui HC, Schmitt FA, Samarasekera N, et al. APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis. J Neurol Neurosurg Psychiatry 2014; 85: 300-5.
86. Raposo N, Viguier A, Cuvinciuc V, Calviere L, Cognard C, Bonneville F, et al. Cortical subarachnoid haemorrhage in the elderly: a recurrent event probably related to cerebral amyloid angiopathy. Eur J Neurol 2011; 18: 597-603.
87. Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997; 204: 272-7.
88. Roch JA, Nighoghossian N, Hermier M, Cakmak S, Picot M, Honnorat J, et al. Transient neurologic symptoms related to cerebral amyloid angiopathy: usefulness of T2∗-weighted imaging. Cerebrovasc Dis 2005; 20: 412-4.
89. Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, et al. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 2009; 73: 2061-70.
90. Shams S, Martola J, Cavallin L, Granberg T, Shams M, Aspelin P, et al. SWI or T2∗: Which MRI sequence to use in the detection of cerebral microbleeds? The karolinska imaging dementia study. AJNR Am J Neuroradiol 2015.
91. Shoamanesh A, Martinez-Ramirez S, Oliveira-Filho J, Reijmer Y, Falcone GJ, Ayres A, et al. Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy. Neurology 2014; 83: 1838-43.
92. Smith DB, Hitchcock M, Philpott PJ. Cerebral amyloid angiopathy presenting as transient ischemic attacks. Case report. J Neurosurg 1985; 63: 963-4.
93. Smith EE, Schneider JA, Wardlaw JM, Greenberg SM. Cerebral microinfarcts: the invisible lesions. Lancet Neurol 2012; 11: 272-82.
94. Smith EE, Vijayappa M, Lima F, Delgado P, Wendell L, Rosand J, et al. Impaired visual evoked flow velocity response in cerebral amyloid angiopathy. Neurology 2008; 71: 1424-30.
95. Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, et al. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol 2012; 11: 241-9.
96. Sperling RA, Jack CR, Jr., Black SE, Frosch MP, Greenberg SM, Hyman BT, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimer's Dement 2011; 7: 367-85.
97. Stehling C, Wersching H, Kloska SP, Kirchhof P, Ring J, Nassenstein I, et al. Detection of asymptomatic cerebral microbleeds: a comparative study at 1.5 and 3.0 T. Acad Radiol 2008; 15: 895-900.
98. Takeda S, Hinokuma K, Yamazaki K, Onda K, Miyakawa T, Ikuta F, et al. The hemorrhage caused by sporadic-type cerebral amyloid angiopathy occurs primarily in the cerebral sulci. Neuropathology 2012; 32: 38-43.
99. Takeda S, Yamazaki K, Miyakawa T, Onda K, Hinokuma K, Ikuta F, et al. Subcortical hematoma caused by cerebral amyloid angiopathy: does the first evidence of hemorrhage occur in the subarachnoid space? Neuropathology 2003; 23: 254-61.
100. van Rooden S, van der Grond J, van den Boom R, Haan J, Linn J, Greenberg SM, et al. Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population. Stroke 2009; 40: 3022-7.
101. Vernooij MW, Ikram MA, Hofman A, Krestin GP, Breteler MMB, van der Lugt A. Superficial siderosis in the general population. Neurology 2009; 73: 202-5.
102. Vernooij MW, Ikram MA, Wielopolski PA, Krestin GP, Breteler MM, van der Lugt A. Cerebral microbleeds: accelerated 3D T2∗-weighted GRE MR imaging versus conventional 2D T2∗-weighted GRE MR imaging for detection. Radiology 2008a; 248: 272-7.
103. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008b; 70: 1208-14.
104. Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly. Ann Neurol 2011; 70: 871-80.
105. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822-38.
106. Wollenweber FA, Buerger K, Mueller C, Ertl-Wagner B, Malik R, Dichgans M, et al. Prevalence of cortical superficial siderosis in patients with cognitive impairment. J Neurol 2014; 261: 277-82.
107. Wu Z, Mittal S, Kish K, Yu Y, Hu J, Haacke EM. Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J Magn Reson Imaging 2009; 29: 177-82.
108. Zhan RY, Tong Y, Shen JF, Lang E, Preul C, Hempelmann RG, et al. Study of clinical features of amyloid angiopathy hemorrhage and hypertensive intracerebral hemorrhage. J Zhejiang University Sci 2004; 5: 1262-9.
109. Zonneveld HI, Goos JD, Wattjes MP, Prins ND, Scheltens P, van der Flier WM, et al. Prevalence of cortical superficial siderosis in a memory clinic population. Neurology 2014; 82: 698-704.